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Abstract
We describe for the first time the synthesis of biocompatible TiO2 nanoparticles containing a functional NH2 group
which are easily dispersible in water. The synthesis of water dispersible TiO2 nanoparticles coated with
mercaptosuccinic acid is also reported. We show that it is possible to exchange the stearic acid from pre-
synthesised fatty acid-coated anatase 5-nm nanoparticles with a range of organic ligands with no change in the
size or morphology. With further organic functionalisation, these nanoparticles could be used for medical imaging
or to carry cytotoxic radionuclides for radioimmunotherapy where ultrasmall nanoparticles will be essential for
rapid renal clearance.
Introduction
Organically functionalised inorganic nanoparticles are
being increasingly studied as a result of their many tech-
nological applications. In particular, the synthesis of inor-
ganic nanoparticles for biomedical applications is being
widely researched. Biomedical applications of inorganic
nanoparticles include biosensing [1], targeted drug delivery
agents [2] and contrast agents in magnetic resonance ima-
ging (MRI) [3,4]. Surface-coated superparamagnetic iron
oxide nanoparticles have been extensively employed as
magnetic resonance signal enhancers that can resolve the
weakness of current MRI techniques. Most recently, it has
been shown that by conjugating surface-coated Au-Fe3O4
nanoparticles to both herceptin and cis-platin, the nano-
particles can act as target-specific nanocarriers to deliver
platin into Her2-positive breast cancer cells with strong
therapeutic results [5]. Furthermore, these nanoparticles
can act as both a magnetic and optical probe for tracking
the platin complex in cells and biological systems. How-
ever, the iron oxide nanoparticles commonly used as MRI
contrast agents have a radius of over 50 nm so that they
have a limited extravasation ability and are subject to easy
uptake by the reticuloendothelial system [6,7]. In order to
enhance biological targeting efficiency, ultrasmall nanopar-
ticles with greatly reduced hydrodynamic sizes are desired.
Recently, ultrasmall (core size of 4.5 nm) c(RGDyK)-
coated Fe3O4 nanoparticles have been synthesised [8], and
results show a dramatic increase in cellular uptake. These
nanoparticles were synthesised via thermal decomposition
of Fe(CO)5 in the presence of the ligand 4-methycatechol
(4-MC). The 4-MC-coated nanoparticles were then conju-
gated with a peptide c(RGDyK) via the Mannich reaction.
There has been much research into the synthesis and
properties of TiO2 nanoparticles since surface-modified
TiO2 nanoparticles have many applications including
photocatalysis [9] and photoelectric conversion [10,11].
Such research has shown that it is facile to make surface-
coated TiO2 nanoparticles with an ultrasmall core size of
3 to 5 nm [12,13]. However, the study of TiO2 nanoparti-
cles for biological applications, which have been shown to
be non-toxic at low doses [14] (5 mg/kg body weight), has
thus far been limited as such TiO2 nanoparticles are gen-
erally synthesised via a nonhydrolytic method and hence
are non-dispersible in water. There are a couple of exam-
ples of functionalised TiO2 nanoparticles which are disper-
sible in water [15,16]; however, in these reports, a broad
size distribution is evidenced (3 to 8 nm).
In this paper, we show that it is possible to synthesise
ultrasmall TiO2 nanoparticles with a core size of 5 nm
with a range of coated short-chain organic functional
groups which are comparable in size to diabodies which
exhibit rapid renal excretion [17]. The organically functio-
nalised nanoparticles are highly dispersible in a range of
solvents, and results show that when coated with aspartic
acid or mercaptosuccinic acid, the nanoparticles are easily
dispersible in water. Hence, for the first time, ultrasmall
biocompatible TiO2 nanoparticles containing a functional
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provided the original work is properly cited.NH2 or SH group have been synthesised. With further
organic functionalisation and conjugation to a targeting
moiety such as a single-chain antibody fragment or to bio-
tin, these nanoparticles could be used to carry multiple
short-lived radionuclides including
99mTc and
67Ga for
medical imaging or to cytotoxic radionuclides for radioim-
munotherapy where ultrasmall nanoparticles will be essen-
tial for rapid renal clearance.
Results and discussion
Nanoparticle preparation
The two-phase thermal synthesis of titanium dioxide
nanoparticles was adapted from a previously described
procedure [13]. Typically, a solution of tert-butylamine
dissolved in water was added to a Teflon-lined steel
autoclave. Separately, titanium(IV) n-propoxide and
stearic acid (SA) were dissolved in toluene and added to
the autoclave. The autoclave was sealed and heated to
180°C for 16 h and allowed to cool to room tempera-
ture. TiO2 nanoparticles were recovered by precipitation
with acetonitrile and isolated by filtration. The “SA-
coated” nanoparticles are dispersible in chloroform and
methanol but are not dispersible in water or acetonitrile.
The approximate number of SA molecules bound to
each nanoparticle core was calculated to be 500 by fol-
lowing an established procedure [12].
Surface functionalisation
Exchange of the TiO2-bound stearic acid chains with
various carboxylic acids was performed by reacting SA-
coated nanoparticles with excess acids in refluxing
chloroform. The resulting nanoparticles could be recov-
ered by removal of solvent, re-suspension in acetonitrile,
and filtration. The nanoparticles were dispersed in
appropriate solvents, and nuclear magnetic resonance
(NMR) spectra were taken. The degree of ligand
exchange was determined by integration of the relevant
signals of the distinct functional groups in the proton
NMR spectra. The results are reported in Table 1.
Approximately 37% of the stearic acid chains could be
exchanged by benzoic acid (Benz) synthesised under
these conditions. Exchange with phthalic acid led to the
formation of non-dispersible nanoparticles, and the
XRD powder pattern obtained indicates a large propor-
tion of unbound phthalic acid that could not be
removed. Synthesis of aspartic acid (Asp) and glycine
(Gly) nanoparticles without the protective Boc group
were unsuccessful, presumably due to the poor solubility
of l-aspartic acid and glycine in chloroform. Only about
25% of the stearic acid chains could be exchanged by
Boc-glycine (Boc-Gly). But ligand exchange with the
bidentate ligands mercaptosuccinic acid (Mercapto) or
Boc-aspartic acid (Boc-Asp) was almost quantitative as
observed by proton NMR (
1HN M R ) .T h eB o cg r o u p
was later cleaved with 4 M HCl in dioxane. The result-
ing nanoparticles from both exchanges were easily dis-
persed in water (ca. 5 mg/ml), and the dispersion is
stable for days without precipitation.
Characterisation of surface-functionalised nanoparticles
The TEM images of SA- and Asp-coated TiO2 nanopar-
ticles are presented in Figure 1. The TEM images for
the other coated nanoparticles and higher magnification
images are displayed in the Additional file (Figures S1
and S2 in Additional file 1). The higher magnification
shows that the nanoparticles prepared are spherical with
a uniform diameter of 5 ± 1 nm, but that the nanoparti-
cles agglomerate. Such agglomeration/aggregation of
TiO2 nanoparticles is well documented and can be
tuned by altering the pH (for example see references
[9,18,19]). The mean hydrodynamic radius was deter-
mined using dynamic light scattering, and the results
are displayed in Table 2 and confirm that when dis-
persed in solution, the coated TiO2 nanoparticles form
agglomerates which vary in size from 141 to 601 nm.
Powder X-ray diffraction (XRD) patterns of SA- and
Asp-coated nanoparticles are shown in Figure 2. The
diffraction patterns show that the anatase phase (JCPDS
no. 21-1272) is formed, and the crystallite size was cal-
culated at 5 nm using the Scherrer formula which is in
good agreement with the TEM images [20]. The XRD
patterns of the Benz, Boc-Gly, Boc-Asp, Mercapto and
Gly surface-modified TiO2 nanoparticles are displayed
in Figures S3 and S4 in Additional file 1. There is no
Table 1 Exchange of the TiO2-bound stearic acid chains
with various carboxylic acids
Entry Carboxylic acid (ligand) Ligand exchange (%)
1 37
a,b
2 20
c,d
3 25
a,b (30)
4 >95
c,b (>95
e)
5 >95
f
aDetermined by
1H NMR (400 MHz, CDCl3).
bXRD powder pattern indicated
essentially pure nanoparticles.
cThe nanoparticles were not dispersible in any
solvent.
dBased on the recovery yield of ligand in acetonitrile.
eDetermined by
1H NMR (400 MHz, D2O) after removal of the Boc group using HCl/dioxane
(ammonium hydrochloride salt is obtained).
fDetermined by
1H NMR (400
MHz, D2O)
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modification.
The presence of the various surface coatings were con-
firmed by Fourier transform infrared spectroscopy
(FTIR) and
1H NMR measurements. The spectrum of
pure stearic acid shows the C = O stretch vibration at
1,700 cm
-1. This band is completely converted into
three new bands in the spectrum of stearic acid-coated
TiO2 nanoparticles as previously reported [12]. Two dif-
ferent carboxylate binding sites can be identified, a brid-
ging complex (νa = 1,620 cm
-1, νs = 1,455 cm
-1)a n da
bidentate complex (νa = 1,521 cm
-1, νs = 1455 cm
-1).
The infrared (IR) spectrum of the Benz-coated nanopar-
ticles (Figure S5 in Additional file 1) shows no evidence
of the free acid C = O stretch, and carboxylate peaks
are detected at 1,630, 1,513 and 1,411 cm
-1, while C = C
aromatic stretches are detected at 1,599 and 1,448 cm
-1.
Upon ligand exchange with Boc-l-aspartic acid and sub-
sequent removal of the Boc group, a change in the IR
spectrum is evidenced (Figure 3). The carboxylate peaks
shift to 1,506 and 1,410 cm
-1, and the C-N stretching
vibration is detected at 1,151 cm
-1.T h eN - Hb e n di s
Figure 1 TEM images of (a) SA-coated and (b) Asp-coated TiO2
nanoparticles.
Table 2 Mean hydronamic radius for the different
carboxylic acid-coated TiO2 nanoparticles determined
from DLS measurements
Carboxylic acid (ligand) Mean hydrodynamic radius (nm)
SA 141
Mercapto 192
Asp 202
Gly 508
BA 601
Figure 2 XRD powder patterns of SA and Asp surface-coated
TiO2 nanoparticles. The patterns show formation of 5-nm anatase
phase.
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-
1, demonstrating the presence of a primary amine; how-
ever, a C = O stretch observable at 1,721 cm
-1 suggests
that not all of the carboxylate groups are bound to the
TiO2 core. Two broad peaks are observed at 3,316 and
3,166 cm
-1 which correspond to N-H stretch peaks; the
broadness of the peaks suggests H bonding interactions
between adjacent molecules. The IR spectra of Benz-,
Boc-Gly-, Boc-Asp-, Mercapto- and Gly-coated nanopar-
ticles are displayed in Figure S5 in Additional file 1.
The Asp nanoparticles were further investigated by
NMR. The proton NMR spectrum of free aspartic acid
(Figure 4) shows a doublet of doublets at 4.09 ppm (
3J =
4.4 Hz;
3J = 6.8 Hz) and two doublets of doublets at
3.05 ppm (
2J =1 8H z ;
3J = 4.4 Hz) and 2.98 ppm (
2J =
18 Hz;
3J = 6.8 Hz). For the aspartic acid-coated nano-
particles, these signals are significantly shifted downfield
(0.05 to 0.17 ppm) and they are slightly broadened. Cur-
iously, the geminal coupling constant for the CH2 group
has apparently disappeared as the CH group appears as
at r i p l e t( J =5 . 6H z )a n dt h eC H 2 g r o u pa p p e a r sa sa
doublet (J = 5.2 Hz). Since the two methylene hydrogens
are diastereotopic, the most likely explanation to this
anomaly is that the chemical environment of both nuclei
is such that they have almost identical chemical shifts.
The discrepancy in the coupling constants (5.6 versus
5.2 Hz) can be explained by the signals given by the
doublet and triplet appearing slightly broad. A two-
dimensional (2D) correlation spectroscopy (COSY)
experiment on these nanoparticles confirmed this cou-
pling (Figure 5). The strong correlation clearly seen
between the CH triplet (4.25 ppm) and the CH2 doublet
(3.09 ppm) indicates that despite the unusual coupling
constants obtained from the
1H NMR, the nuclei in
question are spin coupled. This validates their identities
and indicates that the nanoparticle contains aspartic
acid as a ligand albeit in a slightly altered chemical state
to that of the free acid.
Conclusions
I ns u m m a r y ,w eh a v ec r e a t e daf a c i l er o u t et os y n t h e -
sise ultrasmall surface-coated TiO2 nanoparticles with
a range of organic coatings. Furthermore, the surface-
coated nanoparticles are incredibly robust so that it is
possible to perform ligand exchange reactions on the
outer capping groups without disturbing the overall
size or structure morphology of the nanoparticles.
Results suggest that ligand exchange is most successful
with bidentate ligands as a result of the availability of
two carboxylic acid groups which bind to the TiO2
core.
This two-step approach toward the synthesis of sur-
face-modified TiO2 nanoparticles allows for fine tuning
of the nanoparticle core size in the first step before sur-
face modification with suitable ligands in the second. By
separating the surface modification step from that of the
nanoparticle formation, this method allows for the
Figure 3 Solid-state ATR-FTIR spectra of SA-coated (top) and
Asp-coated (bottom) TiO2 nanoparticles.
Figure 4 Part of the
1H NMR spectrum (400 MHz) in D2O.F o r
Asp-coated nanoparticles (A) and free aspartic acid-coated
nanoparticles (B). Number sign, residual dioxane from Boc
deprotection.
Figure 5 2D COSY NMR spectrum (400 MHz, D2O) of aspartic
acid-coated TiO2 nanoparticles.
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entiation by surface modifications. Additionally, the use
of bifunctional ligands to form the nanoparticle coating
allows for the possibility of post-synthesis modifications
to further functionalise the nanoparticle. This may be
beneficial for use in biological applications as the initial
surface functionalisation can convey improved water
solubility before addition of more biologically relevant
moieties. With further organic functionalisation and
conjugation to a targeting moiety, the biological applica-
tions of the nanoparticles described here include the
transport of multiple short-lived radionuclides including
99Tc and
67Ga for medical imaging or to cytotoxic
radionuclides for radioimmunotherapy. The biological
potential of these new nanostructures is currently being
investigated.
Experimental procedures
General
All ligand exchange reactions were performed under an
argon atmosphere. All reagents were purchased from
Sigma-Aldrich (Sigma-Aldrich Company Ltd, Dorset,
England) and used without further purification. Cleavage
of Boc protecting groups was achieved by stirring in 4 M
HCl/dioxane for 3 h under argon.
Analytical measurements
Routine
1H NMR and COSY data for TiO2 nanoparti-
cles were obtained at 400 MHz on a VarianUnity
INOVA instrument (Agilent Technologies Ltd, UKIn-
frared spectra were obtained from 400 scans at 4 cm
-1
resolution using a Nicolet 380 spectrometer (Thermo
Electron Corporation, Franklin, MA, USA) fitted with a
diamond attenuated total reflectance (ATR) platform. IR
and NMR data reported were obtained at room tem-
perature. Room temperature X-ray diffraction patterns
were collected for the organically coated TiO2 nanopar-
ticles on a Bruker D8 Advance diffractometer (Bruker
AXS Ltd, Coventry, UK) with twin Gobel mirrors using
Cu Ka1 radiation. Data were collected over the range
20° < 2θ < 80°, with a step size of 0.02°. Transmission
electron microscopy images were obtained for the orga-
nically coated TiO2 nanoparticles on a Philips
CM10TEM (FEI Ltd, Netherlands). Dynamic light scat-
tering (DLS) was performed using a Malvern mastersizer
(Malvern Instruments Ltd, Malvern, UK).
Synthesis of titanium dioxide nanoparticles
Titanium dioxide nanoparticles were synthesised by a two-
phase thermal approach adapted from a previously
described procedure [13]. Typically, a solution of 0.15 mL
of tert-butylamine (1.43 mmol) dissolved in 14.5 mL of
water was added to a 45-mL Teflon-lined steel autoclave.
Separately, 0.225 g of titanium(IV) n-propoxide (0.792
mmol) and 0.75 g of stearic acid (2.64 mmol) were dis-
solved in 14.5 mL of toluene and added to the autoclave
without additional stirring. The autoclave was sealed and
heated to 180°C for 16 h and allowed to cool to room tem-
perature. The TiO2 nanoparticles were recovered by preci-
pitation with 90 mL of acetonitrile and isolated
by filtration. Off-white solid;
1HN M R( C D C l 3); δ 0.88
(t,3 H ) ,1 . 2 5( s, 30H) and 2.03 (s, 2H); IR νmax 2,960, 2,915,
2,848, 1,620, 1,521, 1,455, 1,400, 1,300, 1,258, 1,220 and 1,
066 cm
-1.
Procedure for surface modification of nanoparticles
A solution of carboxylic acid (150 mg) in 5 mL chloroform
was added to a reaction vessel containing a dispersion of
“SA-coated” TiO2 nanoparticles (100 mg) in 10 mL
chloroform. The reaction was stirred for 18 h under reflux.
The resultant surface-modified nanoparticles were recov-
ered by evaporation of the solvent in vacuo, re-suspension
in acetonitrile and filtration. Unbound starting material
was removed by repeated washings of the nanoparticles
with acetonitrile.
Benzoic acid exchanged TiO2
Off-white solid; 86% yield;
1H NMR indicates an incom-
plete exchange (37%) of stearic acid with benzoic acid;
1H
NMR (CDCl3); δ 0.88 (t,3 H ) ,1 . 2 8( s, 28H), 1.65 (t,2 H ) ,
2.34 (t,2 H ) ,7 . 4 2( t,1 . 2 H ) ,7 . 5 3( t, 0.6H) and 8.06 (d,
1.2H); IR νmax 2,956, 2,919, 2,849, 1,630, 1,599, 1,513,
1,448 and 1,411 cm
-1.
Glycine exchanged TiO2
Synthesis was performed from Boc-glycine. Cleavage of
the protecting group was achieved by stirring the resulting
nanoparticles under argon in 4 M HCl/dioxane for 3 h.
Off-white solid; 91% yield;
1H NMR indicates an incom-
plete exchange (30%) of stearic acid with glycine;
1HN M R
(CDCl3); δ 0.88 (t, 3H), 1.25 (s, 30H), 2.02 (d, 2H), 2.33 (s,
1H), 3.75 (s,1 . 4 H ) ;I Rνmax 3,319, 3,115, 2,991, 2,928,
1,742, 1,613, 1,495, 1,435, 1,406, 1,337, 1,305, 1,248, 1,118,
1 , 0 6 6a n d9 0 1c m
-1.
Aspartic acid exchanged TiO2
Synthesis was performed from Boc-aspartic acid. Clea-
vage of the protecting group was achieved by stirring the
resulting nanoparticles under argon in 4 M HCl/dioxane
for 3 h. Off-white solid; >95% yield;
1HN M R( D 2O); δ
1.40 (s,0 . 4 H ) ,2 . 0 3( s,0 . 4 H ) ,2 . 1 3( s, 0.3H), 3.09 (d,2 H ,
J = 5.2 Hz), 4.25 (t,1 H ,J = 5.6 Hz); COSY clearly shows
coupling between the protons of the doublet (δ 3.09) and
triplet (δ 4.25); IR νmax 3,316, 3,166, 2,970, 2,910, 1,721,
1,615, 1,506, 1,410, 1,346, 1,296, 1,253, 1,220, 1,151 and
1,066 cm
-1.
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Off-white solid; purification not possible; resulting nano-
particles not dispersible.
Mercaptosuccinic acid exchanged TiO2
Synthesis was performed using mercaptosuccinic acid. To
reduce the possibility of oxidation occurring between mer-
captosuccinic acid moieties, the reaction was performed
under anhydrous conditions but in an otherwise identical
manner to previous exchange reactions. Pale-yellow solid;
>95% yield;
1HN M R( D 2O); δ 2.62 (m,1 H )a n d2 . 9 1
(m,1 H ) ;I Rνmax 2,915, 2,848, 1,685, 1,535, 1,515, 1,442
and 1,384 cm
-1.
Additional material
Additional file 1: Supplementary data. X-ray diffraction, TEM and
spectroscopic data for coated titanium nanoparticles.
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